GlassScriptGore Enform Preperitoneal Biomaterial
Payments companies reported to CMS as associated with Gore Enform Preperitoneal Biomaterial. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gore Enform Preperitoneal Biomaterial, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gore Enform Preperitoneal Biomaterial
These are the largest totals companies reported as associated with Gore Enform Preperitoneal Biomaterial. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Linn | Glenview, IL | Surgery | $171,739.43 |
| Matthew Goldblatt | Milwaukee, WI | Surgery | $168,680.25 |
| Brant Heniford | Charlotte, NC | Surgery | $121,859.03 |
| Garth Jacobsen | San Diego, CA | Surgery | $107,009.11 |
| Howard Levinson | Durham, NC | Plastic Surgery | $68,349.36 |
| Omar Kudsi | Boston, MA | Surgery | $67,947.33 |
| John Fischer | Philadelphia, PA | Plastic Surgery | $57,565.12 |
| Rana Higgins | Milwaukee, WI | Surgery | $49,352.96 |
| Marcos Michelotti | Loma Linda, CA | Surgery | $45,323.62 |
| Leo Derosier | Tallahassee, FL | Surgery | $43,165.39 |
Prescribed Gore Enform Preperitoneal Biomaterial?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.